The average one-year price target for 10x Genomics (BMV:TXG) has been revised to MX$1,361.84 / share. This is an increase of 42.11% from the prior estimate of MX$958.28 dated October 1, 2026. These ...
Much of what scientists know about how genetic differences affect health comes from studying populations outside Africa. This matters because genetic information is increasingly being used to ...
Growth, Share, Opportunities & Competitive Analysis, 2026-2035" report has been added to the DC Market Insights offering. The global Healthcare Data Center Market was valued at USD 15.46 billion in ...
Hologic is acquiring precision oncology company Reveal Genomics. | Hologic is acquiring precision oncology company Reveal ...
Genomics has the potential to play an increasingly important role in healthcare. It could help people receive medicines that ...
IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples ...
AI-enabled cloud, HPC and federated learning accelerate discovery, clinical trials and RWE integration, while precision medicine, multiomics and pharma partnerships drive opportunities.Dublin, Oct.
BGI Genomics' COLOTECT® addresses colorectal cancer in LATAM through innovative non-invasive screening, enhancing early ...
Co., Ltd. (“LC-Bio”), 10x Genomics, and Vitaura (Beijing) Technology Co., Ltd. (“Vitaura”) held a signing ceremony in ...
10x Genomics, Inc. is currently listed on NASDAQ under TXG. One share of TXG stock can currently be purchased for approximately $69.89. Is 10x Genomics, Inc. listed on the NASDAQ or NYSE? 10x Genomics ...
Soybean and other legume crops are central to global food and nutritional security, yet the genetic basis of many ...